• [email protected]
  • Mon - Fri: 9:00 - 18:30 GMT
Search
Rss
Facebook Icon
TwitterCreated with Sketch.
LinkedinCreated with Sketch.
BPRB-LOGO-NEW-Brilliant
  • HOME
  • OUR SERVICES
    • BITCOIN PRESS RELEASE SERVICE
    • SUBMIT YOUR BITCOIN PRESS RELEASE
  • LATEST PRESS RELEASES
  • BLOG
  • OUR TEAM
  • ABOUT US
    • ABOUT
    • CAREERS
Menu
  • HOME
  • OUR SERVICES
    • BITCOIN PRESS RELEASE SERVICE
    • SUBMIT YOUR BITCOIN PRESS RELEASE
  • LATEST PRESS RELEASES
  • BLOG
  • OUR TEAM
  • ABOUT US
    • ABOUT
    • CAREERS

Molecule Partners with VitaDAO and Nevermined Creating First Ever Biopharma IP-to-NFT Transfer for Longevity Research

  • August 19, 2021
  • Supernova Press Release
Molecule Nevermined VitDAO

Press Release: Molecule, a decentralized biopharma marketplace, has developed a novel IP-to-NFT framework with Web3 technology innovator Nevermined. In a historic transaction, the first biopharma IPNFT was successfully transferred to research collective VitaDAO to fund novel longevity therapeutics at the University of Copenhagen.

 

19th August 2021, Basel, Switzerland — For the first time in history, NFTs are being used for a transfer of IP ownership in medical research. This unique milestone is a result of a partnership between biopharma IP marketplace Molecule, and VitaDAO, a decentralized collective (DAO) funding longevity research, and the University of Copenhagen. This innovation is enabled by a groundbreaking data storage solution developed by web3 technology innovator Nevermined.

 

VitaDAO, Nevermined, and Molecule Overcome Biopharma Industry Challenges 

Early-stage biopharma research is the lifeblood that fuels advances in medicine. However, many domains in biopharma suffer from chronic underfunding or commercialization challenges that prevent innovation from reaching patients. Legal complexity, illiquidity of IP assets, and lack of access to investors contribute to the problem for researchers. 

 

By applying Web3 technology, Molecule is enabling a world where researchers get access to an open marketplace that makes novel research and IP discoverable, universally fundable, and distributes ownership. Nevermined’s data storage and access control frameworks create entirely new ways of how the data rights surrounding this IP can be transacted with and accessed.

 

VitaDAO recently became the first benefactor of this advancement. The collective used Molecule’s protocol and IP NFT framework to acquire IP resulting from longevity research run at the Danish Scheibye-Knudsen Lab and transferred ownership to VitaDAO.

Molecule CEO Paul Kohlhaas stated: 

 

“This NFT transfer marks a historic milestone for both the NFT and biopharma space. It’s the first time real-world pharma IP is transacted on a blockchain, while also moving into the custodianship of a DAO.”

 

Combining Legal Frameworks with Web3 Interoperability

The early-stage research phase is plagued by a phenomenon coined the Valley of Death – where funding is hard to obtain, meaning many promising discoveries never make it to market. Molecule is building a marketplace for biopharma IP. 

 

A specialized technical framework combines legal agreements such as IP licenses with the novel technology of NFTs and decentralized secure data storage networks that are coupled with the NFT. By ledgering ownership rights on Ethereum, Molecule is building a marketplace for liquid biopharma research data and IP via NFTs. Researchers and biotechs list their projects and discoveries, receive funding via DeFi, and can connect directly with patients. Paul Kohlhaas added:

 

“IP NFTs could effectively replace patent models and become new value drivers thanks to Nevermined’s data storage frameworks. We hope to enable a myriad of use cases like this, first focusing on longevity and mental health and then broadly becoming a sort of “OpenSea” for Biotech NFTs that helps empower new research organizations like VitaDAO.” 

 

Simultaneously, new vehicles to collaborate and fund research are forming in the web3 space. VitaDAO is a “Decentralised Autonomous Organisation” that collectively funds early longevity research projects via its community contributors. In June 2021, it raised $5 million from hundreds of individuals via a Gnosis batch auction – placing the organization directly into the hands of its community. Now it is on a mission to finance the most promising longevity research endeavors and decentralize their ownership.

 

Want to Live Forever? There’s an NFT for That

The complex requirements for storing, transferring, and accessing IP-related files require more than just a standard NFT. Nevermined implemented its Access Control module to create NFTs on steroids with Molecule. These novel NFTs enable the transacting parties to engage with the underlying protected research data via federated access control. This use case has a wide range of applications in the pharmaceutical industry.

 

 Nevermind CTO Aitor Argomániz stated: 

 

“Access Control allows creators and owners of digital assets to attach conditions to an NFT. Think of things like pricing, verified users, privacy parameters, etc.. At the same time, it acts as a Gateway to guarantee that only parties that fulfill certain conditions can get access to the underlying documents.”

 

The module is also cross-tech-compatible. This allows apps to make secure, critical connections between Ethereum, the cloud (e.g AWS), and decentralized hosting (e.g Arweave). This is the only way to guarantee a Certificate of Authenticity with permanence, traceability, and privacy built-in.

 

Nevermined Socials 

Medium | Discord | Twitter 

 

Molecule Socials 

Medium | Telegram | Twitter  | Discord

 

VitaDao Socials 

Medium | Telegram | Twitter  | Discord

 

Media Contact Details

Contact Name: Oana Ionescu

Contact Email:  [email protected]

 

Molecule is the source of this content. This Press Release is for informational purposes only. The information does not constitute investment advice or an offer to invest. 

You found our newsletter subscription!

Did you know that less than 10% of website visitors ever make it all the way to the page end?!

bitcoin pr buzz logo

Blockchain enthusiasts from the start. We have over 9 years experience in Bitcoin marketing specifically: leveraging our unique expertise, partnerships and experience we bring you the most refined, effective, and value for money Bitcoin marketing and Bitcoin press release service to be found.

Please Note:

Press releases are for informational purposes only. The information does not constitute investment advice or an endorsement by Bitcoin PR Buzz. Bitcoin PR Buzz does not certify the accuracy of the information in press releases published on this website.

Issuers of Press Releases, and not Bitcoin PR Buzz, are solely responsible for the content of press releases, and the accuracy of the content in press releases.

Quick Links

  • Press Release Services
  • Submit Press Release
  • Latest Press Release
  • Social Media Service
  • Copywriting
  • About
  • Careers
  • Terms & Conditions
  • GDPR
  • Token Sale Press Release Policy
  • INC verified
Rss
Facebook-f
Twitter
Linkedin

Coins Accepted Here

bprb
Welcome to Bitcoin PR Buzz!

Your privacy is immensely important to us and we do our best to safeguard your data. We use cookies on this website to improve your experience and to improve our services. We comply with the EU General Data Protection Regulation act also known as GDPR. We wish you a pleasant stay at bitcoinprbuzz.com, if you have any questions please feel free to chat with us below or email [email protected]

I Consent
Cookie settings
More info
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

SAVE & ACCEPT
  • →
  • Contact Us

    Contact Form

  • Telegram